World's Best Scientists 2026 revealed!
George D. Hartman

George D. Hartman

Award Badge
Chemistry
Belgium
2025

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
12831
World Ranking
8836
National Ranking
155

Chemistry

D-Index
66
Citations
13121
World Ranking
7427
National Ranking
92

George D. Hartman publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where George D. Hartman sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 362 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

George D. Hartman D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where George D. Hartman sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 66 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Chemistry in Belgium Leader Award
  • 2022 - Research.com Chemistry in Belgium Leader Award

Overview

George D. Hartman is affiliated with Janssen (Belgium) in Belgium and has contributed to research primarily within the field of Medicine. Their work spans several subfields including Epidemiology, Molecular Biology, Hepatology, Immunology, and Infectious Diseases. The scientist's research focuses on areas related to viral infections, immune responses, and liver diseases.

The main research topics covered by George D. Hartman include:

  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Inflammasome and immune disorders
  • Interferon and immune responses
  • Tryptophan and brain disorders
  • Viral Infections and Outbreaks Research
  • Pneumocystis jirovecii pneumonia detection and treatment

Recent publications featuring George D. Hartman as an author demonstrate their active involvement in antiviral and immunology research. Selected papers include:

  • The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening, 2024, Bioorganic & Medicinal Chemistry Letters
  • P450s under Restriction (PURE) Screen Using HepaRG and Primary Human Hepatocytes for Discovery of Novel HBV Antivirals, 2020, ACS Medicinal Chemistry Letters

Other notable recent papers in related fields, though authored by colleagues, appear in venues where George D. Hartman is a frequent contributor:

  • Identification of a new class of HBV capsid assembly modulator, 2021, Bioorganic & Medicinal Chemistry Letters
  • Oxadiazepinone HBV capsid assembly modulators, 2021, Bioorganic & Medicinal Chemistry Letters
  • Diazepinone HBV capsid assembly modulators, 2022, Bioorganic & Medicinal Chemistry Letters

George D. Hartman collaborates with several frequent co-authors, including:

  • Rusty L. Montgomery
  • Sarah U. Tronnes
  • Rebecca C. Coll
  • Michael Marleaux
  • Inga V. Hochheiser

The scientist generally publishes in the following venues, reflecting their research focus in medicinal chemistry and experimental medicine:

  • Bioorganic & Medicinal Chemistry Letters
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Experimental Medicine
  • ACS Medicinal Chemistry Letters

Best Publications

  • Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors.

    Craig W. Lindsley;Zhijian Zhao;William H. Leister;Ronald G. Robinson

  • Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia

    Christopher D. Cox;Michael J. Breslin;David B. Whitman;John D. Schreier

  • Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.

    Hartman Gd;Egbertson Ms;Halczenko W;Laswell Wl

  • Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.

    Robert B. Lobell;Charles A. Omer;Marc T. Abrams;Hema G. Bhimnathwala

  • Non-peptide Fibrinogen Receptor Antagonists. 2. Optimization of a Tyrosine Template as a Mimic for Arg-Gly-Asp

    Egbertson Ms;Chang Ct;Duggan Me;Gould Rj

  • Inhibition of a mitotic motor protein: where, how, and conformational consequences

    Youwei Yan;Vinod Sardana;Bei Xu;Carl Homnick

  • Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo.

    Craig W. Lindsley;David D. Wisnoski;William H. Leister;Julie A. O'brien

  • Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors.

    Zhijian Zhao;William H. Leister;Ronald G. Robinson;Stanley F. Barnett

  • Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer

    Christopher D Cox;Paul J Coleman;Michael J Breslin;David B Whitman

  • Hepatitis b antiviral agents

    George D. Hartman;Osvaldo A. Flores

  • Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP

    Christopher D. Cox;Michael J. Breslin;Brenda J. Mariano;Paul J. Coleman

  • Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties

    Paul J. Coleman;John D. Schreier;Christopher D. Cox;Michael J. Breslin

  • Sulfonamide fibrinogen receptor antagonists

    Melissa S. Egbertson;William L. Laswell;George D. Hartman;Mark E. Duggan

  • High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein

    Klaus Klumpp;Angela M. Lam;Christine Lukacs;Robert Vogel

  • New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides.

    Prugh Jd;Hartman Gd;Mallorga Pj;McKeever Bm

  • Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.

    William D. Shipe;James C. Barrow;Zhi Qiang Yang;Craig W. Lindsley;Craig W. Lindsley

  • Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection

    Man Fung Yuen;Edward J. Gane;Dong Joon Kim;Frank Weilert

  • Nonpeptide alphavbeta3 antagonists. 8. In vitro and in vivo evaluation of a potent alphavbeta3 antagonist for the prevention and treatment of osteoporosis.

    John H Hutchinson;Wasyl Halczenko;Karen M Brashear;Michael J Breslin

  • Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.

    B. Wesley Trotter;Kausik K. Nanda;Nathan R. Kett;Christopher P. Regan

  • Farnesyltransferase inhibitors versus Ras inhibitors

    Jackson B Gibbs;Samuel L Graham;George D Hartman;Kenneth S Koblan

Frequent Co-Authors

Nancy E. Kohl
Nancy E. Kohl Unnatural Products
Craig W. Lindsley
Craig W. Lindsley Vanderbilt University
John J. Renger
John J. Renger MSD (United States)
Jackson B. Gibbs
Jackson B. Gibbs George Washington University
Gideon A. Rodan
Gideon A. Rodan MSD (United States)
Le T. Duong
Le T. Duong MSD (United States)
Allen Oliff
Allen Oliff GlaxoSmithKline (United States)
Klaus Klumpp
Klaus Klumpp Janssen (Belgium)
Samuel Graham
Samuel Graham Georgia Institute of Technology
Christopher Cox
Christopher Cox Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse career paths, particularly in forensic science and related fields. Many students explore specialized roles such as autopsy technician jobs, which combine chemistry knowledge with hands-on technical skills in medical examinations.

For those seeking affordable education options, identifying the cheapest online forensic science degree programs is crucial. These programs provide essential coursework in chemistry, biology, and criminal justice, offering a cost-effective path to enter the forensic field without compromising quality.

Advancing education through a masters in forensic psychology online can complement a chemistry background by focusing on the psychological aspects of criminal behavior, enhancing career flexibility and opportunities in forensic investigations or profiling.

Exploring forensic career paths and salary details helps students understand the potential job markets and earnings in this interdisciplinary field. Careers in forensic science typically require strong chemistry foundations combined with specialized forensic training to excel in various roles.

Best Scientists Citing George D. Hartman

Trending Scientists